Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention

Phase 1

Completed

Conditions: Graft-versus-host Disease

Interventions: Drug: Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention

First Posted Date: 2020-08-07

Last Posted Date: 2024-10-16

Lead Sponsor: NYU Langone Health

Target Recruit Count: 46

Registration Number: NCT04503616

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Adherence Connection for Counseling, Education, and Support (ACCESS) II

Not Applicable

Completed

Conditions: HIV Infections

Interventions: Behavioral: ACCESS II mHealth Intervention
Behavioral: ACCESS II control condition

First Posted Date: 2020-08-05

Last Posted Date: 2025-01-24

Lead Sponsor: NYU Langone Health

Target Recruit Count: 60

Registration Number: NCT04499781

Locations: 🇺🇸
Jacobi Medical Center, Bronx, New York, United States

Feasibility Open Label Study Evaluating The Use Of Process-Instructed Self Neuro-Modulation (PRISM) For Post-Traumatic Stress Disorder

Not Applicable

Withdrawn

Conditions: Post-traumatic Stress Disorder

Interventions: Device: PROCESS-INSTRUCTED SELF NEURO-MODULATION (PRISM)

First Posted Date: 2020-08-03

Last Posted Date: 2021-06-14

Lead Sponsor: NYU Langone Health

Registration Number: NCT04496557

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19)

Phase 2

Completed

Conditions: Covid19

Interventions: Drug: Bardoxolone Methyl
Drug: Placebo

First Posted Date: 2020-07-31

Last Posted Date: 2022-01-13

Lead Sponsor: NYU Langone Health

Target Recruit Count: 40

Registration Number: NCT04494646

Locations: 🇺🇸
NYU Winthrop Hospital, Mineola, New York, United States
🇺🇸
NYU Langone Health, New York, New York, United States
🇺🇸
HSHS St. John's Hospital (Prairie Education and Research Cooperative), Springfield, Illinois, United States

and more 5 locations

SLAP Repair vs. Biceps Tenodesis in Patients Under 30: A Randomized Clinical Trial

Not Applicable

Completed

Conditions: SLAP Tear

Interventions: Procedure: Self-Locking Tenotomy
Procedure: Biceps Tenodesis

First Posted Date: 2020-07-31

Last Posted Date: 2024-08-12

Lead Sponsor: NYU Langone Health

Target Recruit Count: 100

Registration Number: NCT04494932

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Belatacept in De Novo Heart Transplantation

Phase 2

Recruiting

Conditions: Heart Transplantation

Interventions: Drug: Belatacept
Drug: Tacrolimus
Drug: Mycophenolate Mofetil
Drug: Corticosteroid

First Posted Date: 2020-07-20

Last Posted Date: 2025-01-22

Lead Sponsor: NYU Langone Health

Target Recruit Count: 12

Registration Number: NCT04477629

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States
🇺🇸
Columbia University, New York, New York, United States

Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)

Phase 3

Recruiting

Conditions: AVB - Atrioventricular Block
Fetal AVB

Interventions: Drug: Dexamethasone
Drug: IVIG

First Posted Date: 2020-07-16

Last Posted Date: 2025-04-09

Lead Sponsor: NYU Langone Health

Target Recruit Count: 1300

Registration Number: NCT04474223

Locations: 🇺🇸
University of California - Los Angeles (UCLA), Los Angeles, California, United States
🇺🇸
Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio, United States
🇺🇸
UH Rainbow Babies / Children's Hospital, Cleveland, Ohio, United States

and more 21 locations

Tenodesis vs. Self-locking Tenotomy in Long Head of the Biceps Tendon Lesions: A Randomized Clinical Trial

Not Applicable

Terminated

Conditions: Tenodesis
Tenotomy

Interventions: Procedure: Self-locking "T" Tenotomy
Procedure: Biceps Tenodesis

First Posted Date: 2020-07-13

Last Posted Date: 2024-05-31

Lead Sponsor: NYU Langone Health

Target Recruit Count: 42

Registration Number: NCT04468906

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Electronic Cigarettes as a Harm Reduction Strategy Among Patients With COPD

Not Applicable

Completed

Conditions: COPD

Interventions: Other: E-cigarette (EC)
Other: Nicotine Replacement Therapy (NRT)
Behavioral: Smoking Harm Reduction Counseling Sessions

First Posted Date: 2020-07-10

Last Posted Date: 2023-06-15

Lead Sponsor: NYU Langone Health

Target Recruit Count: 146

Registration Number: NCT04465318

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)

Phase 2

Active, not recruiting

Conditions: Opioid Use Disorder (OUD)

Interventions: Drug: SL-BUP
Drug: XR-BUP
Drug: XR-NTX
Behavioral: MM
Behavioral: MMR
Behavioral: MMD

First Posted Date: 2020-07-09

Last Posted Date: 2025-06-06

Lead Sponsor: NYU Langone Health

Target Recruit Count: 2190

Registration Number: NCT04464980

Locations: 🇺🇸
Adapt Integrated Health Care, Winston, Oregon, United States
🇺🇸
University of Arkansas for Medical Sciences (UAMS) / Center for Addiction Services and Treatment (CAST), Little Rock, Arkansas, United States
🇺🇸
Tarzana Treatment Centers, Inc., Tarzana, California, United States

and more 17 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy